150 related articles for article (PubMed ID: 10095109)
1. Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray.
Wang K; Gan L; Jeffery E; Gayle M; Gown AM; Skelly M; Nelson PS; Ng WV; Schummer M; Hood L; Mulligan J
Gene; 1999 Mar; 229(1-2):101-8. PubMed ID: 10095109
[TBL] [Abstract][Full Text] [Related]
2. Comparison of gene expression profiles between primary tumor and metastatic lesions in gastric cancer patients using laser microdissection and cDNA microarray.
Wang L; Zhu JS; Song MQ; Chen GQ; Chen JL
World J Gastroenterol; 2006 Nov; 12(43):6949-54. PubMed ID: 17109515
[TBL] [Abstract][Full Text] [Related]
3. Assessment of gene expression profile by cDNA microarray analysis.
Ghazizadeh M; Kawanami O; Araki T
J Nippon Med Sch; 2001 Dec; 68(6):460-1. PubMed ID: 11744925
[No Abstract] [Full Text] [Related]
4. Identification of DNA copy number changes in microdissected serous ovarian cancer tissue using a cDNA microarray platform.
Tsuda H; Birrer MJ; Ito YM; Ohashi Y; Lin M; Lee C; Wong WH; Rao PH; Lau CC; Berkowitz RS; Wong KK; Mok SC
Cancer Genet Cytogenet; 2004 Dec; 155(2):97-107. PubMed ID: 15571795
[TBL] [Abstract][Full Text] [Related]
5. [Monitoring novel ovarian carcinoma associated genes using cDNA expression microarray].
Chang XH; Cheng YX; Zhang XY; Cui H; Feng J
Zhonghua Fu Chan Ke Za Zhi; 2003 Jun; 38(6):322-4. PubMed ID: 12895369
[TBL] [Abstract][Full Text] [Related]
6. Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays.
Martoglio AM; Tom BD; Starkey M; Corps AN; Charnock-Jones DS; Smith SK
Mol Med; 2000 Sep; 6(9):750-65. PubMed ID: 11071270
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning of mesothelin, a differentiation antigen present on mesothelium, mesotheliomas, and ovarian cancers.
Chang K; Pastan I
Proc Natl Acad Sci U S A; 1996 Jan; 93(1):136-40. PubMed ID: 8552591
[TBL] [Abstract][Full Text] [Related]
8. Circular RNA and gene expression profiles in gastric cancer based on microarray chip technology.
Sui W; Shi Z; Xue W; Ou M; Zhu Y; Chen J; Lin H; Liu F; Dai Y
Oncol Rep; 2017 Mar; 37(3):1804-1814. PubMed ID: 28184940
[TBL] [Abstract][Full Text] [Related]
9. Profile and validation of dysregulated long non‑coding RNAs and mRNAs in ovarian cancer.
Lu YM; Wang Y; Liu SQ; Zhou MY; Guo YR
Oncol Rep; 2018 Nov; 40(5):2964-2976. PubMed ID: 30132558
[TBL] [Abstract][Full Text] [Related]
10. Molecular cloning and characterization of a novel human BTB domain-containing gene, BTBD10, which is down-regulated in glioma.
Chen J; Xu J; Ying K; Cao G; Hu G; Wang L; Luo C; Lou M; Mao Y; Xie Y; Lu Y
Gene; 2004 Sep; 340(1):61-9. PubMed ID: 15556295
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiles in primary ovarian serous papillary tumors and normal ovarian epithelium: identification of candidate molecular markers for ovarian cancer diagnosis and therapy.
Santin AD; Zhan F; Bellone S; Palmieri M; Cane S; Bignotti E; Anfossi S; Gokden M; Dunn D; Roman JJ; O'Brien TJ; Tian E; Cannon MJ; Shaughnessy J; Pecorelli S
Int J Cancer; 2004 Oct; 112(1):14-25. PubMed ID: 15305371
[TBL] [Abstract][Full Text] [Related]
12. Prostasin, a potential serum marker for ovarian cancer: identification through microarray technology.
Mok SC; Chao J; Skates S; Wong K; Yiu GK; Muto MG; Berkowitz RS; Cramer DW
J Natl Cancer Inst; 2001 Oct; 93(19):1458-64. PubMed ID: 11584061
[TBL] [Abstract][Full Text] [Related]
13. Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas.
Schummer M; Ng WV; Bumgarner RE; Nelson PS; Schummer B; Bednarski DW; Hassell L; Baldwin RL; Karlan BY; Hood L
Gene; 1999 Oct; 238(2):375-85. PubMed ID: 10570965
[TBL] [Abstract][Full Text] [Related]
14. Screening for genes associated with ovarian cancer prognosis.
Chang XH; Zhang L; Yang R; Feng J; Cheng YX; Cheng HY; Ye X; Fu TY; Cui H
Chin Med J (Engl); 2009 May; 122(10):1167-72. PubMed ID: 19493465
[TBL] [Abstract][Full Text] [Related]
15. RAD21 and KIAA0196 at 8q24 are amplified and overexpressed in prostate cancer.
Porkka KP; Tammela TL; Vessella RL; Visakorpi T
Genes Chromosomes Cancer; 2004 Jan; 39(1):1-10. PubMed ID: 14603436
[TBL] [Abstract][Full Text] [Related]
16. [Expression of mesothelin mRNA and protein in ovarian carcinomas].
Bi SN; Dai SZ; Yao Q; Che YC; Wang N
Zhonghua Zhong Liu Za Zhi; 2008 Apr; 30(4):288-91. PubMed ID: 18788634
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially expressed genes in esophageal squamous cell carcinoma (ESCC) by cDNA expression array: overexpression of Fra-1, Neogenin, Id-1, and CDC25B genes in ESCC.
Hu YC; Lam KY; Law S; Wong J; Srivastava G
Clin Cancer Res; 2001 Aug; 7(8):2213-21. PubMed ID: 11489794
[TBL] [Abstract][Full Text] [Related]
18. Analysis of gene expression patterns of ovarian cancer cell lines with different metastatic potentials.
Bai F; Feng J; Cheng Y; Shi J; Yang R; Cui H
Int J Gynecol Cancer; 2006; 16(1):202-9. PubMed ID: 16445634
[TBL] [Abstract][Full Text] [Related]
19. Identification of differentially expressed genes in oral squamous cell carcinoma.
Arora S; Matta A; Shukla NK; Deo SV; Ralhan R
Mol Carcinog; 2005 Feb; 42(2):97-108. PubMed ID: 15599930
[TBL] [Abstract][Full Text] [Related]
20. Systematic identification and molecular characterization of genes differentially expressed in breast and ovarian cancer.
Dahl E; Sadr-Nabavi A; Klopocki E; Betz B; Grube S; Kreutzfeld R; Himmelfarb M; An HX; Gelling S; Klaman I; Hinzmann B; Kristiansen G; Grützmann R; Kuner R; Petschke B; Rhiem K; Wiechen K; Sers C; Wiestler O; Schneider A; Höfler H; Nährig J; Dietel M; Schäfer R; Rosenthal A; Schmutzler R; Dürst M; Meindl A; Niederacher D
J Pathol; 2005 Jan; 205(1):21-8. PubMed ID: 15586368
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
